Sage Rhino Capital LLC Gsk PLC Transaction History

Sage Rhino Capital LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	BUY	$42.05 - $47.77 $7,947 - $9,028	189 Added 2.45%	7,919 $345,000
Q1 2022 Apr 27, 2022	BUY	$40.23 - $47.74 $16,413 - $19,477	408 Added 5.57%	7,730 $337,000
Q4 2021 Feb 04, 2022	BUY	$38.88 - $45.31 $38,296 - $44,630	985 Added 15.54%	7,322 $323,000
Q3 2021 Oct 18, 2021	BUY	$38.79 - $43.16 $17,610 - $19,594	454 Added 7.72%	6,337 $242,000
Q2 2021 Jul 27, 2021	BUY	$36.52 - $41.46 $214,847 - $243,909	5,883 New	5,883 $234,000
Q4 2020 Feb 03, 2021	SELL	$34.07 - $39.94 $193,960 - $227,378	-5,693 Closed	0 $0
Q3 2020 Nov 05, 2020	BUY	$38.11 - $42.99 $21,570 - $24,332	566 Added 11.04%	5,693 $214,000
Q2 2020 Jul 30, 2020	BUY	$37.87 - $43.58 $194,159 - $223,434	5,127 New	5,127 $209,000
Q1 2020 Apr 29, 2020	SELL	$32.47 - $48.83 $166,571 - $250,497	-5,130 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$42.0 - $48.25 $14,112 - $16,212	336 Added 7.01%	5,130 $240,000
Q3 2019 Oct 25, 2019	BUY	$40.46 - $43.52 $193,965 - $208,634	4,794 New	4,794 $205,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Sage Rhino Capital LLC with notifications on news.